U.S. Colorectal Cancer Screening Market is driven by Technological...

U.S. Colorectal Cancer Screening Market is driven by Technological Advances

Сообщение 2025-06-16 07:01:24

The U.S. Colorectal Cancer Screening Market encompasses various diagnostic products including colonoscopy systems, fecal immunochemical tests (FIT), stool DNA assays, and emerging blood-based biomarkers. Colonoscopy remains the gold standard for direct visualization and polyp removal, while FIT and stool DNA tests offer non-invasive, cost-effective alternatives with high sensitivity and specificity. Recent technological advances—such as AI-powered image processing during endoscopy and multiplex biomarker panels—have elevated diagnostic precision, reduced false-positive rates, and enhanced patient compliance.

The U.S. colorectal cancer screening market size was valued at US$ 6.41 Bn in 2025 and is expected to reach US$ 10.77 Bn by 2032, grow at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032.

U.S. Colorectal Cancer Screening Market These innovations, coupled with robust market research and market insights, are addressing long-standing market challenges like procedure reluctance and limited access to specialists. Supportive reimbursement policies and increasing awareness of colorectal cancer risk factors among aging populations are fueling market growth and uncovering new market opportunities. Integrated digital reporting and telehealth-enabled follow-up are improving workflow efficiency and patient engagement, driving business growth for industry companies.

Get More Insight On : U.S. Colorectal Cancer Screening Market

Get this Report in Japanese Language: 米国大腸がん検査市場

Get this Report in Korean Language: 미국대장암검진시장

Read More Related Articles- Understanding Colorectal Cancer Screening in the United States